Featured Articles
Latest Articles
Article
Fast growth MAb market to offer great rewards to a select few over 2009-15
Datamonitor predicts that the MAb sector will record a near double-digit growth rate over 2009-15, making it the fastest growing molecule type segment in the prescription pharmaceutical industry. With total sales derived by a select band of blockbuster products, the MAb sector is a tough market to break in to, but one that offers high rewards.
Article
Cytheris Initiates INSPIRE 3, a Phase II Clinical Trial of CYT107 in Chronically Infected HIV Patients
Phase II clinical program will evaluate the effect of repeated cycles of the company’s investigative immune-modulator in the treatment of Immunological Non-Responders.
Advertisement